Innovations and Challenges in Molecular Probe-Based Precision Theranostics for Genitourinary System Tumors
10.3971/j.issn.1000-8578.2025.25.0351
- VernacularTitle:泌尿系统肿瘤分子探针精准诊疗的创新与挑战
- Author:
Mingwei SUN
1
;
Pengyu GUO
1
;
Wanhai XU
2
Author Information
1. Department of Urology, Harbin Medical University Cancer Hospital, Harbin 150081, China;NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin 150001, China.
2. NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin 150001, China;Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
- Publication Type:SPECIALFEATURE
- Keywords:
Molecular probe;
Urinary system tumor;
Precision diagnosis and treatment;
Multimodal imaging
- From:
Cancer Research on Prevention and Treatment
2025;52(10):811-817
- CountryChina
- Language:Chinese
-
Abstract:
Genitourinary system tumors, as a major clinical challenge posing a serious threat to human health, urgently require breakthroughs in the construction of a precision diagnosis and treatment system. The innovative application of molecular imaging technologies, particularly the development of novel molecular probes, is revolutionizing the diagnostic and therapeutic paradigms for urinary tumors. The application of novel molecular probes in the early diagnosis and staging of genitourinary tumors, the role of multimodal molecular imaging probes in guiding precision surgery/radiotherapy, and the clinical translation challenges and strategies for theranostic-integrated probes are systematically reviewed in this article to provide valuable insights and references for related research and clinical practice.
